156 related articles for article (PubMed ID: 12937838)
1. Effect of tumor stage and nephrectomy on CD62P expression and sP-selectin concentration in renal cancer.
Mantur M; Kemona H; Kozłowski R; Kemona-Chetnik I
Neoplasma; 2003; 50(4):262-5. PubMed ID: 12937838
[TBL] [Abstract][Full Text] [Related]
2. Does renal carcinoma affect the expression of P-selectin on platelets?
Mantur M; Kemona H; Pietruczuk M; Wasiluk A
Neoplasma; 2002; 49(4):243-5. PubMed ID: 12382022
[TBL] [Abstract][Full Text] [Related]
3. Changes in platelet CD 62P expression and soluble P-selectin concentration in surgically treated colorectal carcinoma.
Dymicka-Piekarska V; Matowicka-Karna J; Osada J; Kemona H; Butkiewicz AM
Adv Med Sci; 2006; 51():304-8. PubMed ID: 17357330
[TBL] [Abstract][Full Text] [Related]
4. Soluble P-selectin concentration in patients with colorectal cancer.
Dymicka-Piekarska V; Butkiewicz A; Matowicka-Karna J; Kemona H
Neoplasma; 2005; 52(4):297-301. PubMed ID: 16059645
[TBL] [Abstract][Full Text] [Related]
5. Platelet surface CD62P and CD63, mean platelet volume, and soluble/platelet P-selectin as indexes of platelet function in atrial fibrillation: a comparison of "healthy control subjects" and "disease control subjects" in sinus rhythm.
Choudhury A; Chung I; Blann AD; Lip GY
J Am Coll Cardiol; 2007 May; 49(19):1957-64. PubMed ID: 17498581
[TBL] [Abstract][Full Text] [Related]
6. Soluble, platelet-bound, and total P-selectin as indices of platelet activation in congestive heart failure.
Chung I; Choudhury A; Patel J; Lip GY
Ann Med; 2009; 41(1):45-51. PubMed ID: 18618353
[TBL] [Abstract][Full Text] [Related]
7. The influence of hyperlipidemia on platelet activity markers in patients after ischemic stroke.
Pawelczyk M; Baj Z; Chmielewski H; Kaczorowska B; Klimek A
Cerebrovasc Dis; 2009; 27(2):131-7. PubMed ID: 19047793
[TBL] [Abstract][Full Text] [Related]
8. The origin of P-selectin as a circulating plasma protein.
Fijnheer R; Frijns CJ; Korteweg J; Rommes H; Peters JH; Sixma JJ; Nieuwenhuis HK
Thromb Haemost; 1997 Jun; 77(6):1081-5. PubMed ID: 9241736
[TBL] [Abstract][Full Text] [Related]
9. Platelet activation in acute, decompensated congestive heart failure.
Chung I; Choudhury A; Lip GY
Thromb Res; 2007; 120(5):709-13. PubMed ID: 17287016
[TBL] [Abstract][Full Text] [Related]
10. Relationship between soluble P-selectin and inflammatory factors (interleukin-6 and C-reactive protein) in colorectal cancer.
Dymicka-Piekarska V; Matowicka-Karna J; Gryko M; Kemona-Chetnik I; Kemona H
Thromb Res; 2007; 120(4):585-90. PubMed ID: 17169411
[TBL] [Abstract][Full Text] [Related]
11. Prognostic impact of postoperative C-reactive protein level in patients with metastatic renal cell carcinoma undergoing cytoreductive nephrectomy.
Tatokoro M; Saito K; Iimura Y; Fujii Y; Kawakami S; Kihara K
J Urol; 2008 Aug; 180(2):515-9. PubMed ID: 18550105
[TBL] [Abstract][Full Text] [Related]
12. Platelet function alterations and their relation to P-selectin (CD62P) expression in children with iron deficiency anemia.
Yıldırım ZK; Orhan MF; Büyükavcı M
Blood Coagul Fibrinolysis; 2011 Mar; 22(2):98-101. PubMed ID: 21245745
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of platelet count in patients with renal cell carcinoma.
Erdemir F; Kilciler M; Bedir S; Ozgok Y; Coban H; Erten K
Urol Int; 2007; 79(2):111-6. PubMed ID: 17851278
[TBL] [Abstract][Full Text] [Related]
14. Clinically apparent atherosclerotic disease in diabetes is associated with an increase in platelet microparticle levels.
Tan KT; Tayebjee MH; Lim HS; Lip GY
Diabet Med; 2005 Dec; 22(12):1657-62. PubMed ID: 16401308
[TBL] [Abstract][Full Text] [Related]
15. Platelet activation in clinical haemodialysis: LMWH as a major contributor to bio-incompatibility?
Gritters M; Borgdorff P; Grooteman MP; Schoorl M; Schoorl M; Bartels PC; Tangelder GJ; Nubé MJ
Nephrol Dial Transplant; 2008 Sep; 23(9):2911-7. PubMed ID: 18364368
[TBL] [Abstract][Full Text] [Related]
16. Microparticle-associated P-selectin reflects platelet activation in preeclampsia.
Lok CA; Nieuwland R; Sturk A; Hau CM; Boer K; Vanbavel E; Vanderpost JA
Platelets; 2007 Feb; 18(1):68-72. PubMed ID: 17365856
[TBL] [Abstract][Full Text] [Related]
17. Activation of blood platelets in chronic hepatitis and liver cirrhosis P-selectin expression on blood platelets and secretory activity of beta-thromboglobulin and platelet factor-4.
Panasiuk A; Prokopowicz D; Zak J; Matowicka-Karna J; Osada J; Wysocka J
Hepatogastroenterology; 2001; 48(39):818-22. PubMed ID: 11462931
[TBL] [Abstract][Full Text] [Related]
18. Platelet products prepared by different methods of sedimentation undergo platelet activation differently during storage.
Skripchenko A; Kurtz J; Moroff G; Wagner SJ
Transfusion; 2008 Jul; 48(7):1469-77. PubMed ID: 18482181
[TBL] [Abstract][Full Text] [Related]
19. Platelet-derived microparticles and soluble P-selectin as platelet activation markers in patients with atopic dermatitis.
Tamagawa-Mineoka R; Katoh N; Ueda E; Masuda K; Kishimoto S
Clin Immunol; 2009 Jun; 131(3):495-500. PubMed ID: 19217350
[TBL] [Abstract][Full Text] [Related]
20. Relationships between optical aggregometry (type born) and flow cytometry in evaluating ADP-induced platelet activation.
Sbrana S; Della Pina F; Rizza A; Buffa M; De Filippis R; Gianetti J; Clerico A
Cytometry B Clin Cytom; 2008 Jan; 74(1):30-9. PubMed ID: 17630652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
